Pain After Insufflation for Robotic Sacrocolpopexy (PAIRS) Trial

NCT ID: NCT04858438

Last Updated: 2021-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-02

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates post-operative pain between different insufflation pressures during robotic-assisted sacrocolpopexy. Subjective pain and narcotic usage after surgery will be measured.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective single-blind randomized controlled trial of adult women undergoing robotic-assisted sacrocolpopexy for pelvic organ prolapse. Each surgery will be performed by a board-certified Female Pelvic Medicine \& Reconstructive Surgery (FPMRS) surgeon with a standard technique other than pneumoperitoneum level. A sacrocolpopexy for apical prolapse may be performed at the same time as a hysterectomy and other clinically indicated procedures if desired by the patient and as part of the standard of care. Patients will be stratified by hysterectomy prior to randomization. Postoperatively, patients will be evaluated with a Visual Analogue Scale (VAS) as well as prescribed narcotic analgesic use and followed up to 2 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pelvic Organ Prolapse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients will be randomized to receive either standard pneumoperitoneum (15 mmHg) versus a lower level of pneumoperitoneum (12 mmHg).
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Patients will be unaware of their study group status and unaware of level of pneumoperitoneum used during their surgical procedure.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Insufflation Group

Patients will receive standard insufflation during surgery (15 mm Hg).

Group Type ACTIVE_COMPARATOR

Insufflation during surgery

Intervention Type PROCEDURE

This is the amount of insufflation using during the surgical procedure.

Low Insufflation Group

Patients will receive a lower level of insufflation during surgery (12 mm Hg or lower).

Group Type EXPERIMENTAL

Insufflation during surgery

Intervention Type PROCEDURE

This is the amount of insufflation using during the surgical procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insufflation during surgery

This is the amount of insufflation using during the surgical procedure.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scheduled to have a robotic-assisted sacrocolpopexy surgery for pelvic organ prolapse.
* Age 18-90 years
* Can read and understand the consent form and consents to the procedure

Exclusion Criteria

* Patients undergoing other procedures
* Patients who do not consent to participate.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Henry Ford Health System

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ascension St. John Hospital

Detroit, Michigan, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gabriella Rustia, MD

Role: CONTACT

313-343-6708

Muhammad F Aslam, MD

Role: CONTACT

313-343-3494

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gabriella M Rustia, MD

Role: primary

Muhammad F Aslam, MD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Rustia GM, Baracy MG Jr, Khair E, Hagglund KH, Aslam MF. Pain With Differing Insufflation Pressures During Robotic Sacrocolpopexy: A Randomized Controlled Trial. Obstet Gynecol. 2023 Jul 1;142(1):151-159. doi: 10.1097/AOG.0000000000005231. Epub 2023 Jun 7.

Reference Type DERIVED
PMID: 37348093 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1716019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.